We have a special assignment: your health

Vaccines have been proven to protect against serious illnesses, helping people live healthier, longer lives. They don’t just benefit individuals, but also strengthen entire communities by reducing the spread of disease and easing the pressure on healthcare systems. Vaccines are one of the most effective ways to protect public health.

At FVR, we support this mission by conducting reliable, science-based research on a wide variety of vaccines. We study their quality, safety, and efficacy to make sure they offer the protection people need – today and in the future.

WHY CHOOSE FVR FOR YOUR VACCINE STUDY?

  • We have the capability to enroll thousands of participants in clinical trials, and tens of thousands in large pragmatic trials
  • Several decades of vaccine study experience from over 160 studies, throughout all age groups
  • Strong references for post-licensure studies, and a favourable Finnish operating environment
  • Our core focus is on running vaccine trials and research
  • We have a continuous development mindset, agility, and drive to innovate together with our partners
for The pharma sector
overview of 2024
Please accept the Marketing cookies to watch this video.

Key figures (year end 2024)

172Studies
90298Participants (clinical trials)
10Clinics
108Professionals

Our research expertise

With decades of experience and internationally recognised scientific excellence, we conduct high-quality vaccine research. Our extensive network of clinics provides an outstanding foundation for this work. We offer clinical expertise across all phases of vaccine research (phases 1–4), as well as in studies assessing the effectiveness and safety of vaccines already in use. We also have strong capabilities in Real-World Evidence (RWE) studies and pragmatic vaccine trials, leveraging Finland’s comprehensive health registers and data resources.

past and ongoing clinical studies
references for post-licensure studies

We advance science-based vaccination expertise and public acceptance in Finland and globally through high-quality vaccine research.

Newsfeed

  • Changes in the leadership team of FVR

    Three new members have been appointed to the FVR – Finnish Vaccine Research leadership team. Katja Volanto-Lumppio, Head of Research Services and Satu Grönberg, Head of People, joined the leadership team on 1 December 2024. Laura Grant has been appointed as Director, Marketing and Communications starting on 10 January 2025. Laura will be responsible for…

    Read more

See All News

Research clinics